Fundraising FoxAllander Biotechnologies
Aurora, US · Founded 2023 · Delaware corporation
Find your way into Allander Biotechnologies
Sign up to see every warm intro you have to Allander Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allander Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Allander Biotechnologies is a biotechnology company. The page lists leadership roles but provides no usable detail about the company's products or focus.
Founders & leadership
BZ
Bing ZhaoNamed on SEC filing
XW
XiaoJing WangNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2023
▶$1MraisedOct 2023 · 2 investors · Other TechnologyRule 506(b)
▶$1MraisedOct 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Bing ZhaoDirector
- XiaoJing WangExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Cerecor Inc.Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
Allogene TherapeuticsAllogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches. The company aims to expand CAR T treatment access through scalable manufacturing, lower costs, and faster treatment delivery.
Companies working in the same space as Allander Biotechnologies.
Frequently asked questions
- What does Allander Biotechnologies do?
- Allander Biotechnologies is a biotechnology company. The page lists leadership roles but provides no usable detail about the company's products or focus.
- How much funding has Allander Biotechnologies raised?
- Allander Biotechnologies has disclosed $1M raised across 1 round.
- Where is Allander Biotechnologies headquartered?
- Allander Biotechnologies is headquartered in Aurora, US.